Preclinical use of longitudinal MRI for screening the efficacy of s-nitrosoglutathione in treating spinal cord injury

Journal of Magnetic Resonance Imaging

Volumn 33, Issue 6, 2011, Pages 1301-1311

  Peter, Cheng Te Chou ^a   Shunmugave, Anandakumar ^b   El Sayed, Hanaa ^a   Desouki, Mohamed Mokhtar ^b   Nguyen, Shaun A ^b   Khan, Mushfiquddin ^b   Singh, Inderjit ^b   Bilgen, Mehmet ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

drug treatment efficacy; preclinical screening; Spinal cord injury; translational research

Indexed keywords

S NITROSOGLUTATHIONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; COGNITION; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFICACY; EDEMA; EXCISION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LAMINECTOMY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; TISSUE PRESERVATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; DRUG EVALUATION, PRECLINICAL; DRUG MONITORING; EDEMA; FEMALE; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; S-NITROSOGLUTATHIONE; SPINAL CORD INJURIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958252534     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22574     Document Type: Article

References (34)

1. Schwartz M, Yoles E. Immune-based therapy for spinal cord repair: autologous macrophages and beyond. J Neurotrauma 2006;23:360-370. (Pubitemid 43739276)
2. Campbell SJ, Zahid I, Losey P, et al. Liver Kupffer cells control the magnitude of the inflammatory response in the injured brain and spinal cord. Neuropharmacology 2008;55:780-787.
3. Massa SM, Yang T, Xie Y, et al. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J Clin Invest 2010;120:1774-1785.
4. Shunmugavel A, Khan M, Te Chou PC, et al. Simvastatin protects bladder and renal functions following spinal cord injury in rats. J Inflamm (Lond) 2010;7:17.
5. Lammertse D, Dungan D, Dreisbach J, et al. Neuroimaging in traumatic spinal cord injury: an evidence-based review for clinical practice and research. J Spinal Cord Med 2007;30:205-214. (Pubitemid 47092891)
6. Wong DF, Tauscher J, Grunder G. The role of imaging in proof of concept for CNS drug discovery and development. Neuropsychopharmacology 2009;34:187-203.
7. Bilgen M, Al-Hafez B, Alrefae T, et al. Longitudinal magnetic resonance imaging of spinal cord injury in mouse: changes in signal patterns associated with the inflammatory response. Magn Reson Imaging 2007;25:657-664. (Pubitemid 46817798)
8. Chou PC, Tatar I, Bilgen M. Multimodal MRI evaluation of acute mild-contusive injury in mouse spinal cord. Neuroanatomy 2008; 7:83-92.
9. Tatar I, Chou PC, Desouki MM, El Sayed H, Bilgen M. Evaluating regional blood spinal cord barrier dysfunction following spinal cord injury using longitudinal dynamic contrast-enhanced MRI. BMC Med Imaging 2009;9:10.
10. Beckmann N, Mueggler T, Allegrini PR, Laurent D, Rudin M. From anatomy to the target: contributions of magnetic resonance imaging to preclinical pharmaceutical research. Anat Rec 2001; 265:85-100. (Pubitemid 32281261)
11. Mihai G, Nout YS, Tovar CA, et al. Longitudinal comparison of two severities of unilateral cervical spinal cord injury using magnetic resonance imaging in rats. J Neurotrauma 2008;25:1-18. (Pubitemid 351161067)
12. Ditor DS, John S, Cakiroglu J, Kittmer C, Foster PJ, Weaver LC. Magnetic resonance imaging versus histological assessment for estimation of lesion volume after experimental spinal cord injury. Laboratory investigation. J Neurosurg Spine 2008;9:301-306.
13. Nout YS, Mihai G, Tovar CA, Schmalbrock P, Bresnahan JC, Beattie MS. Hypertonic saline attenuates cord swelling and edema in experimental spinal cord injury: a study utilizing magnetic resonance imaging. Crit Care Med 2009;37:2160-2166.
14. Patel CB, Cohen DM, Ahobila-Vajjula P, Sundberg LM, Chacko T, Narayana PA. Effect of VEGF treatment on the blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced magnetic resonance imaging. J Neurotrauma 2009;26:1005-1016.
15. Shen J, Zhong XM, Duan XH, et al. Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury. Acad Radiol 2009;16: 1142-1154.
16. Chou P, Gunsoy ML, Desouki MM, et al. Preclinical screening of a potential drug treatment for spinal cord injury using magnetic resonance imaging. In: Proceedings of the 17th Annual Scientific Meeting and Exhibition of ISMRM, Honolulu, Hawaii. 2009. (abstract 1299).
17. Khan M, Sekhon B, Giri S, et al. S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb Blood Flow Metab 2005; 25: 177-192. (Pubitemid 40171200)
18. Khan M, Im YB, Shunmugavel A, et al. Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J Neuroinflammation 2009; 6: 32.
19. Foster MW, McMahon TJ, Stamler JS,. S-nitrosylation in health and disease. Trends Mol Med 2003; 9: 160-168. (Pubitemid 36626705)
20. Martinez-Ruiz A, Lamas S,. S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc Res 2004; 62: 43-52. (Pubitemid 38326810)
21. Chiueh CC,. S-nitrosoglutathione (GSNO) mediates brain response to hypoxia. Pediatr Res 2002; 51: 414. (Pubitemid 34267308)
22. Gu Z, Kaul M, Yan B, et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002; 297: 1186-1190. (Pubitemid 36193354)
23. Fortenberry JD, Owens ML, Chen NX, Brown LA,. S-nitrosoglutathione inhibits TNF-alpha-induced NFkappaB activation in neutrophils. Inflamm Res 2001; 50: 89-95. (Pubitemid 32210149)
24. Mohr S, Zech B, Lapetina EG, Brune B,. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem Biophys Res Commun 1997; 238: 387-391. (Pubitemid 27464394)
25. Rauhala P, Lin AM, Chiueh CC,. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J 1998; 12: 165-173. (Pubitemid 28080186)
26. Schrammel A, Gorren AC, Schmidt K, Pfeiffer S, Mayer B,. S-nitrosation of glutathione by nitric oxide, peroxynitrite, and (*)NO/O(*-). Free Radic Biol Med 2003; 34: 1078-1088.
27. Kaposzta Z, Martin JF, Markus HS,. Switching off embolization from symptomatic carotid plaque using S-nitrosoglutathione. Circulation 2002; 105: 1480-1484. (Pubitemid 34263281)
28. Khan M, Jatana M, Elango C, Paintlia AS, Singh AK, Singh I,. Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide 2006; 15: 114-124. (Pubitemid 44175884)
29. Prasad R, Giri S, Nath N, Singh I, Singh AK,. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Glia 2007; 55: 65-77. (Pubitemid 44845510)
30. Bilgen M,. A new device for experimental modeling of central nervous system injuries. Neurorehabil Neural Repair 2005; 19: 219-226. (Pubitemid 41216297)
31. Neumann M, Wang Y, Kim S, et al. Assessing gait impairment following experimental traumatic brain injury in mice. J Neurosci Methods 2009; 176: 34-44.
32. Ek CJ, Habgood MD, Callaway JK, et al. Spatio-temporal progression of grey and white matter damage following contusion injury in rat spinal cord. PLoS One 2010; 5: e12021.
33. Basso DM, Beattie MS, Bresnahan JC,. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.
34. Savidge TC, Newman P, Pothoulakis C, et al. Enteric glia regulate intestinal barrier function and inflammation via release of S- nitrosoglutathione. Gastroenterology 2007; 132: 1344-1358. (Pubitemid 46656255)